Brian Pittman
Statistician 3Cards
About
Research
Publications
2026
Reversible alterations of brain acetate metabolism associated with alcohol consumption
Kumaragamage C, Jiang L, Angarita G, de Graaf R, Guidone E, Coppoli A, Behar K, Gulanski B, Pittman B, Weinzimer S, Rothman D, Krystal J, Mason G. Reversible alterations of brain acetate metabolism associated with alcohol consumption. Neuropsychopharmacology 2026, 1-9. PMID: 42218273, DOI: 10.1038/s41386-026-02455-6.Peer-Reviewed Original ResearchAn opioid-withholding human laboratory paradigm during opioid agonist treatment for opioid use disorder and chronic pain: Phase- and dose-dependent effects of cannabidiol
P. A. Costa G, Sofuoglu M, Compton P, Ranganathan M, Pittman B, De Aquino J. An opioid-withholding human laboratory paradigm during opioid agonist treatment for opioid use disorder and chronic pain: Phase- and dose-dependent effects of cannabidiol. Neuropsychopharmacology 2026, 1-10. PMID: 42162267, PMCID: PMC13213852, DOI: 10.1038/s41386-026-02443-w.Peer-Reviewed Original ResearchLower synaptic density in mood circuitry underlies depression in Parkinson’s disease
Cayir S, Naganawa M, Volpi T, Sadabad F, Dias M, Yang Y, Elliott S, Ansari M, Elshahat A, Pittman B, Esterlis I, Nabulsi N, Huang Y, Sanacora G, Comley R, Finnema S, Carson R, Tinaz S, Matuskey D, Holmes S. Lower synaptic density in mood circuitry underlies depression in Parkinson’s disease. Brain Communications 2026, 8: fcag136. PMID: 42109687, PMCID: PMC13152014, DOI: 10.1093/braincomms/fcag136.Peer-Reviewed Original ResearchSynaptic density imaging in behavioral variant frontotemporal dementia: A comparison of 18F‐SynVesT‐1 and 18F‐FDG PET
Fesharaki‐Zadeh A, Cayir S, Ibrahim W, Yang Y, Gallezot J, Naganawa M, Wu Y, Toyonaga T, Sadabad F, O'Dell R, Pittman B, Nabulsi N, Strittmatter S, Carson R, Huang Y, van Dyck C, Mecca A, Matuskey D. Synaptic density imaging in behavioral variant frontotemporal dementia: A comparison of 18F‐SynVesT‐1 and 18F‐FDG PET. Alzheimer's & Dementia 2026, 22: e71283. PMID: 41954197, PMCID: PMC13063251, DOI: 10.1002/alz.71283.Peer-Reviewed Original ResearchThis study investigates synaptic density imaging in behavioral variant frontotemporal dementia, showing that SV2A PET detects more pronounced synaptic loss than glucose hypometabolism using FDG PET, aiding early diagnosis and monitoring.Additional analyses do not implicate opioid signaling in the antidepressant effects of ketamine
Yoon G, Pittman B, Krystal J. Additional analyses do not implicate opioid signaling in the antidepressant effects of ketamine. The International Journal Of Neuropsychopharmacology 2026, 29: pyag011. PMID: 41818343, PMCID: PMC13064640, DOI: 10.1093/ijnp/pyag011.Peer-Reviewed Original ResearchNaltrexone/bupropion for binge-eating disorder: A human laboratory investigation of mechanisms
McKee S, Lydecker J, Pittman B, Jastreboff A, DiLeone R, Lavery M, Grilo C. Naltrexone/bupropion for binge-eating disorder: A human laboratory investigation of mechanisms. Drug And Alcohol Dependence Reports 2026, 19: 100428. PMID: 41867954, PMCID: PMC13000475, DOI: 10.1016/j.dadr.2026.100428.Peer-Reviewed Original ResearchLegal blood alcohol concentration limits and alcohol-attributable traffic mortality rates: an analysis across 165 countries
Jimenez Chavez C, Peltier M, Mokwuah A, Bin-Mahfouz A, Verplaetse T, Zakiniaeiz Y, Kohler R, Garcia-Rivas V, Banini B, Raval N, Pittman B, McKee S. Legal blood alcohol concentration limits and alcohol-attributable traffic mortality rates: an analysis across 165 countries. EClinicalMedicine 2026, 93: 103794. PMID: 41768275, PMCID: PMC12945517, DOI: 10.1016/j.eclinm.2026.103794.Peer-Reviewed Original ResearchHigher drinking frequency corresponds to lower synaptic density in people with alcohol use disorder
Zakiniaeiz Y, Raval N, Riordan W, Nabulsi N, Huang Y, Pittman B, Matuskey D, Angarita G, Bonomi R, McKee S, Hillmer A, Cosgrove K. Higher drinking frequency corresponds to lower synaptic density in people with alcohol use disorder. Journal Of Clinical Investigation 2026, 136: e199989. PMID: 41528802, PMCID: PMC13038192, DOI: 10.1172/jci199989.Peer-Reviewed Original ResearchThis study investigates how chronic alcohol use reduces brain synaptic density in key regions, linking greater drinking frequency to more severe synaptic deficits and cognitive impairments.
2025
Comparing single‐ and repeat‐dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial
Schindler E, Gottschalk C, Pittman B, D'Souza D. Comparing single‐ and repeat‐dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial. Headache The Journal Of Head And Face Pain 2025, 66: 885-895. PMID: 41459830, DOI: 10.1111/head.70024.Peer-Reviewed Original ResearchImaging Metabotropic Glutamate Receptor 5 and Excitatory Neural Activity in Autism
Naples A, Yang Y, Gravel P, Toyonaga T, Sadabad F, Koohsari S, Pittman B, Gallezot J, Pisani L, Finn C, Cramer-Benjamin S, Herman N, Rosenthal L, Franke C, Walicki B, Rodden I, Hillmer A, Esterlis I, Ropchan J, Nabulsi N, Huang Y, Wolf J, Carson R, McPartland J, Matuskey D. Imaging Metabotropic Glutamate Receptor 5 and Excitatory Neural Activity in Autism. American Journal Of Psychiatry 2025, 183: 58-69. PMID: 41366835, DOI: 10.1176/appi.ajp.20241084.Peer-Reviewed Original ResearchAutistic adults have lower levels of a key brain receptor linked to excitatory activity, suggesting a molecular basis for altered brain function in autism.
News
News
- July 01, 2026
Bassir Nia, Co-Investigators to Study Cannabinoid Receptor Type 1 Availability in Individuals with Opioid Use Disorder
- May 21, 2026Source: Neuropsychopharmacology
An Opioid-Withholding Human Laboratory Paradigm During Opioid Agonist Treatment for Opioid Use Disorder and Chronic Pain: Phase- and Dose-Dependent Effects of Cannabidiol
- January 20, 2026
Yale Study: Higher Drinking Frequency Corresponds to Lower Synaptic Density in People with Alcohol Use Disorder
- July 29, 2025Source: Journal of Addiction Medicine
The Role of Childhood Trauma in Chronic Pain and Substance Use Among Individuals Receiving Methadone Treatment for Opioid Use Disorder